Liska V, Treska V, Holubec L, Skalický T, Sutnar A, Topolcan O, Fínek J
Chirurgická klinika FN, Plzen.
Rozhl Chir. 2006 Feb;85(2):86-9.
In the period of November 1999 - June 2003 78 patients with colorectal liver metastases (CLM) were operated at Department of Surgery, University Hospital in Pilsen. In multifactorial analysis there were evaluated these clinical parametres: age of patient, sex, localisation of primary tumor, Dukes classification, grading, staging and histology of primary tumor, histologicaly free resection margin, chemotherapy or actinotherapy after colorectal operation, type of liver resection, complications after liver surgery, radicality of liver surgery, lateralisation of liver metastatic process, number of metastases, blood transfusions, repeated liver surgery, volume of metastases. Kaplan-Meier method was used for evaluation of survival rate and disease free interval (DFI). Statistical analysis of studied clinical parametres was performed by Log-rank test and Wilcoxon test. The medium DFI after liver surgery was 16 months for all the patients (range 0-55 months), the medium DFI for patients after radical surgery was 18 months. The medium survival time after liver surgery for all the patients was 30 months (range 1-57 months), for patients after radical surgery it was 32 months, and for patients after palliative surgery the medium disease free interval was 29 months (range 5-30 months). The 4-year survival rate after the liver surgery was for all the patients 37%. The factors statistically significant for a disease free interval after liver surgery were bilaterality of metastatic process, the microscopically free resection line, radical surgical treatment versus RFA and unilaterality of metastatic process. The authors proved followed factors as statistically significant for survival rate: grading of colorectal cancer and age of patients. The prediction of early recurrence enables us to choose adequate surgical therapy or its extension by oncological therapy. More thorough follow up of patients with tendency to early recurrence of CLM helps to early diagnosis of relaps and it increases the posssibility of repeated liver surgery.
1999年11月至2003年6月期间,78例结直肠癌肝转移(CLM)患者在比尔森大学医院外科接受了手术治疗。在多因素分析中,评估了以下临床参数:患者年龄、性别、原发肿瘤部位、Dukes分期、分级、原发肿瘤的分期和组织学类型、组织学切缘阴性、结直肠手术后的化疗或放疗、肝切除类型、肝脏手术后的并发症、肝脏手术的根治性、肝转移过程的侧别、转移灶数量、输血情况、再次肝脏手术、转移灶体积。采用Kaplan-Meier法评估生存率和无病生存期(DFI)。通过对数秩检验和Wilcoxon检验对所研究的临床参数进行统计学分析。所有患者肝脏手术后的中位DFI为16个月(范围0-55个月),根治性手术后患者的中位DFI为18个月。所有患者肝脏手术后的中位生存时间为30个月(范围1-57个月),根治性手术后患者为32个月,姑息性手术后患者的中位无病生存期为29个月(范围5-30个月)。所有患者肝脏手术后的4年生存率为37%。对肝脏手术后无病生存期具有统计学意义的因素为转移过程的双侧性、显微镜下切缘阴性、根治性手术治疗与射频消融治疗以及转移过程的单侧性。作者证实以下因素对生存率具有统计学意义:结直肠癌分级和患者年龄。早期复发的预测使我们能够选择合适的手术治疗或通过肿瘤治疗进行扩展。对CLM有早期复发倾向的患者进行更全面的随访有助于早期诊断复发,并增加再次肝脏手术的可能性。